A new study showed a great connection between the levels of protein called “Slit Guidance Ligand 2” in both the glass body (the gel in the eye), the blood and the results of the nervous perception tests in middle -aged individuals.
This is the first study that records the relative concentrations of the “Slit Gedens Legandal 2” protein in the glass body and blood plasma, and proves the presence of connection between the levels of “Slit Gedens Legandal 2” from both sources and cognitive function.
The study was conducted by researchers from the University of Boston in the United States, and its results were published in the Journal of Alzheimer’s disease in September, and the Yurrick Alert website was written about.
79 individuals, at an average age of 56, underwent ophthalmology, as well as nervous perception assessments.
Samples of the glass and plasma body were gathered, then the samples were analyzed using highly sensitive optical immunosural analogal assaulted and designed, especially to detect “Slit Gedens Legund 2”.
The researchers have found that low levels of “Slit Gedens Leganda 2” in the glass body is linked to the low grades in the Montreal Cagenitive Assessment, a cognitive impairment tool, as well as a decrease in the standard of immediate remembrance of words, a measure of verbal memory.
The high levels of “Slit Gedens Leganda 2” in the plasma have been associated with the low levels of Montreal’s cognitive evaluation.
It is worth noting that the vitreous body contains up to 7 times the amount of “Slit Gedens Leganda 2” in the plasma.